Central role of RET in thyroid cancer

Area of Science:

• Oncology
• Molecular Biology
• Developmental Biology

Background:

• The rearranged during transfection (RET) receptor tyrosine kinase plays a crucial role in the development of neural crest-derived cells, kidney, and male germ cells.
• Aberrant RET signaling, specifically gain-of-function mutations, is implicated in the pathogenesis of several human malignancies.

Purpose of the Study:

• To highlight the significance of RET in both normal development and cancer.
• To underscore the therapeutic potential of targeting RET in oncological treatments.

Main Methods:

• Literature review of RET's role in development and cancer.
• Analysis of RET mutations in various human cancers.
• Evaluation of RET as a therapeutic target.

Main Results:

• RET is essential for the development of critical tissues and cell types.
• Gain-of-function mutations in RET are frequently observed in thyroid carcinomas, lung adenocarcinomas, and myeloproliferative disorders.
• RET protein alterations are strongly associated with tumorigenesis.

Conclusions:

• RET is a critical developmental gene and a driver of multiple human cancers.
• Targeting RET offers a promising therapeutic strategy for treating RET-driven malignancies.